GWLL OTC
Goldenwell Biotech, Inc.
1W: +0.0%
1M: -1.5%
3M: +32.6%
YTD: -76.2%
1Y: +244.8%
$0.69
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$139
-94.1% ▼
Gross Profit
$64
-94.2% ▼
Operating Income
-$123K
-5.3% ▼
Net Income
-$131K
-12.5% ▼
EPS (Diluted)
$-0.00
-8.3% ▼
EBITDA
-$123K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $16K | $48K | $2K | $139 |
| YoY Growth | +0.0% | +0.0% | +199.4% | -95.1% | -94.1% |
| Cost of Revenue | $0 | $8K | $23K | $1K | $75 |
| Gross Profit | $0 | $8K | $25K | $1K | $64 |
| Gross Margin | — | 52.5% | 52.7% | 47.4% | 46.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6K | $127K | $1M | $118K | $123K |
| Operating Expenses | $6K | $127K | $1M | $118K | $123K |
| Operating Income | -$6K | -$118K | -$985K | -$117K | -$123K |
| Operating Margin | — | -740.7% | -2060.9% | -4995.5% | -88559.7% |
| Interest Expense | $0 | $0 | $0 | $0 | $8K |
| Income Before Tax | -$6K | -$117K | -$985K | -$117K | -$131K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$6K | -$117K | -$985K | -$117K | -$131K |
| Net Margin | — | -732.6% | -2060.9% | -4995.5% | -94602.9% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.01 | $-0.00 | $-0.00 |
| EBITDA | $0 | $0 | $0 | $0 | -$123K |
| Shares Outstanding | 96M | 91M | 96M | 96M | 99M |